She is the first sickle cell patient to receive a revolutionary gene therapy using a tool called CRISPR. She now shares her symptom-free success story on a global stage.
CRISPR Therapy Signifies the Dominant Era of Clinical Medicine by Karishma Abhishek on March 17, 2021 at 8:15 PM GlobalData s (a leading data and analytics company) Pharmaceutical Intelligence Centre.
The current treatment of cancer drugs can only prolong life by a few years at best, whereas CRISPR-based therapies will be able to prolong the life of cancer patients by decades. Thereby they may inevitably transform the lives of patients and the shape of the industry if they are brought to market.
Among the race to introduce these CRISPR therapies to the clinic, there are three leading companies - CRISPR Therapeutics, Intellia Therapeutics and